InternationalJournal ofOncologyKnockdown of the Bcl-2 gene increases sensitivity to EGFR tyrosine kinase inhibitors in the H1975 lung cancer cell line harboring T790M mutation
Computationally designed high specificity inhibitors delineate the roles of BCL2 family proteins in cancer Proteomic characteristics reveal the signatures and the risks of T1 colorectal cancer metastasis to lymph nodes Predictive nonlinear modeling of malignant myelopoiesis and tyrosine kinase inhibitor therapy Optimal cancer evasion in a dynamic immune microenvironment generates diverse post-escape tumor antigenicity profiles
Targeting BCL-2 in Cancer: Advances, Challenges, and Perspectives
International Journal of Molecular Medicine BCL2‑regulated apoptotic process in myocardial ischemia‑reperfusion injury (Review)
The PROTAC selectively degrading Bcl-xL represents a novel Hedgehog pathway inhibitor with capacity of combating resistance to Smoothened inhibitors while sparing bone growth AbstractCitation styles
Biological properties of the BCL-2 family protein BCL-RAMBO, which regulates apoptosis, mitochondrial fragmentation, and mitophagy
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma